TOWA Pharmaceutical Co (TSE:4553) YoY EBITDA Growth : 2,603.82% (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is TOWA Pharmaceutical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. TOWA Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 2,603.82%.

TOWA Pharmaceutical Co's EBITDA per Share for the three months ended in Dec. 2023 was 円145.47.

TOWA Pharmaceutical Co YoY EBITDA Growth Historical Data

The historical data trend for TOWA Pharmaceutical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co YoY EBITDA Growth Chart

TOWA Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

6.39

4.42

16.19

-24.61

75.65

TOWA Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-50.70	192.17	45.70	2,603.82	1,189.87

TOWA Pharmaceutical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

TOWA Pharmaceutical Co's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(879.62	-	500.772)	/	\| 500.772 \|
=	75.65 %

TOWA Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(145.472	-	-5.81)	/	\| -5.81 \|
=	2,603.82 %

TOWA Pharmaceutical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

TOWA Pharmaceutical Co (TSE:4553) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (TSE:4553) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

6QC:Germany

Address

2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580

Website

http://www.towayakuhin.co.jp

TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (TSE:4553) Headlines

No Headlines